Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
National Institutes of Health opportunity PAR-25-040
Organization Types
UniversitiesNGOsSMEsGovernment Agencies
Eligible Countries / Regions
National Institutes of HealthPAR-25-040Grants.gov